tetraethylammonium has been researched along with Aortic Diseases in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorigo, P | 1 |
| Maragno, I | 1 |
| Santostasi, G | 1 |
| Fraccarollo, D | 1 |
1 other study available for tetraethylammonium and Aortic Diseases
| Article | Year |
|---|---|
Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta.
Topics: Adrenergic Uptake Inhibitors; Animals; Aorta; Aortic Diseases; Endothelin Receptor Antagonists; Endo | 1999 |